基于ICF的老年肌少症功能测量工具的内容和心理测量特性比较

doi:10.3969/j.issn.1006-9771.2024.03.004

《中国康复理论与实践》 ›› 2024, Vol. 30 ›› Issue (3): 273-280.doi: 10.3969/j.issn.1006-9771.2024.03.004

• 专题基于ICF测量工具的测量内容与心理测量特性研究 • 上一篇下一篇

基于ICF的老年肌少症功能测量工具的内容和心理测量特性比较

刘辉^1a^,^1b, 尹航², 胡承红³, 贾绍辉^1a, 封叶文哲^1a, 胡庆奎^1a^,^1b()

1.武汉体育学院，a.运动医学院;b. 运动健康智能装备湖北省工程研究中心，湖北武汉市 430079
2.武汉商学院，湖北武汉市 430056
3.武汉市按摩医院，湖北武汉市 430022

收稿日期:2024-02-07 出版日期:2024-03-25 发布日期:2024-04-01
通讯作者: 胡庆奎 E-mail:19264431@qq.com
作者简介:刘辉(1980-)，男，汉族，湖北黄石市人，硕士，副教授，主要研究方向：体质健康促进、适应性体育、ICF-CY。
胡庆奎(1981-)，男，土家族，湖北恩施市人，博士，讲师，主要研究方向：骨科疾病治疗与康复，运动损伤治疗与康复。
基金资助:
1."十四五"湖北省高等学校优势特色学科(鄂教研[2021]5号);2武汉体育学院中青年科研创新团队项目(21KT14)

Content and psychometric properties of functional measurements in patients with sarcopenia based on ICF

LIU Hui^1a^,^1b, YIN Hang², HU Chenghong³, JIA Shaohui^1a, FENG Yewenzhe^1a, HU Qingkui^1a^,^1b()

1. a. School of Sport Medicine; b. Engineering Research Center of Sports Health Intelligent Equipment of Hubei Province, Wuhan Sports University, Wuhan, Hubei 430079, China
2. Wuhan Business University, Wuhan, Hubei 430056, China
3. Wuhan Massage Hospital, Wuhan, Hubei 430022, China

Received:2024-02-07 Published:2024-03-25 Online:2024-04-01
Contact: HU Qingkui E-mail:19264431@qq.com
Supported by:
The 14th Five-Year-Plan Advantageous and Characteristic Disciplines of Colleges and Universities in Hubei Province under Grant (2021-05);Young and Middle-Aged Scientific Research and Innovation Team Project of Wuhan Sports University(21KT14)

摘要/Abstract

摘要：

目的探讨老年肌少症测量工具的内容和心理测量特性。

方法采用《国际功能、残疾和健康分类》(ICF)联系和编码规则，对7种老年肌少症测量工具，包括力量、行走协助、从椅子起立、上楼梯和跌倒量表(SARC-F)，Ishii测试，小型肌肉萎缩风险评估-7(MSRA-7)，6分钟步行测试(6MWT)，Barthel指数(BI)，简易体能状况量表(SPPB)和世界卫生组织残疾评估量表(WHODAS 2.0)的测量项目进行内容分析与编码，并探讨各测量工具的心理测量特性。

结果根据ICF将7种测量工具分为身体功能和结构类、活动和参与类以及两类都涉及的综合类。SARC-F对应的编码涉及肌肉力量功能(b730)、步行(d450)和改变身体的基本姿势(d410)等。Ishii测试对应的编码涉及肌肉力量功能(b730)和体重维持功能(b530)。MSRA-7对应的编码包括步行(d450)、不随意运动反应功能(b755)和肌肉耐力功能(b740)等。6MWT对应的编码为步行(d450)。SPPB对应的编码涉及改变身体的基本姿势(d410)、随意运动控制功能(b760)和步行(d450)。BI对应的编码包括吃(d550)、喝(d560)、盥洗自身(d510)和护理身体各部(d520)等。WHODAS 2.0对应的编码涉及注意力功能(b140)、掌握技能(d155)、交流-接收-口头讯息(d310)和社区生活(d910)等。SARC-F敏感性较低~中等，特异性中等~优秀。Ishii测试敏感性中等~良好，特异性一般~良好，诊断效果良好。MSRA-7敏感性中等~良好，特异性一般，诊断效果一般~中等；MSRA-5敏感性一般~良好，特异性一般，诊断效果中等。6MWT敏感性、诊断效果均为一般~中等，特异性一般。SPPB敏感性一般，特异性一般~中等，诊断效果一般~优秀。BI信度良好。WHODAS 2.0信度优秀。

结论肌少症测量工具分为身体功能和结构类、活动和参与类以及综合类。7种测量工具的心理测量特性敏感性范围较低~优秀，特异性范围为一般~优秀。

关键词: 老年人, 肌少症, 筛查, 测量, 评估

Abstract:

Objective To explore the content and psychometric properties of sarcopenia measurements for older adults.

Methods Using the International Classification of Functioning, Disability and Health (ICF) linking and coding rules, a content analysis were conducted on the seven types of measurement tools for geriatric sarcopenia, including Strength, Assistance with walking, Rising from a chair, Climbing stairs, and Falls (SARC-F); Ishii Test; Mini Sarcopenia Risk Assessment-7 (MSRA-7); 6-minute walk test (6MWT); Barthel Index (BI); Short Physical Performance Battery (SPPB); and World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), and psychometric property was explored.

Results The seven measurement tools can be categorized into body functions and structures, activities and participation, and comprehensive categories. ICF coding for SARC-F involved muscle power functions (b730), walking (d450), changing basic body position (d410), etc. Ishii Test involved muscle power functions (b730) and weight maintenance functions (b530). MSRA-7 involved walking (d450), involuntary movement reaction functions (b755), muscle endurance functions (b740), etc. ICF coding for 6MWT involved walking (d450). SPPB involved changing basic body position (d410), control voluntary movement functions (b760), and walking (d450). BI involved eating (d550), drinking (d560), washing oneself (d510), caring for body parts (d520), etc. WHODAS 2.0 involved attention functions (b140), acquiring skills (d155), communication-receiving-verbal messages (d310), community life (d910), etc. SARC-F was low to medium in sensitivity, and medium to excellent in specificity. Ishii Test was medium to good in sensitivity, average to good in specificity, and good in diagnostic performance. MSRA-7 was medium to good in sensitivity, average in specificity, and average to medium in diagnostic performance, while MSRA-5 was average to good in sensitivity, average in specificity, and medium in diagnostic performance. 6MWT was average to medium in sensitivity, and average in specificity. SPPB was average in sensitivity, average to medium in specificity, and average to excellent in diagnostic performance. BI was good in reliability, and WHODAS 2.0 was excellent in reliability.

Conclusion The measurement tools for sarcopenia can be categorized into body functions and structures, activities and participation, and comprehensive assessment tools combining the above. The psychometric properties of the seven measurement tools are low to excellent in sensitivity and average to excellent in specificity.

Key words: older adults, sarcopenia, screening, measurement, assessment

中图分类号:

R685

刘辉, 尹航, 胡承红, 贾绍辉, 封叶文哲, 胡庆奎. 基于ICF的老年肌少症功能测量工具的内容和心理测量特性比较[J]. 《中国康复理论与实践》, 2024, 30(3): 273-280.

LIU Hui, YIN Hang, HU Chenghong, JIA Shaohui, FENG Yewenzhe, HU Qingkui. Content and psychometric properties of functional measurements in patients with sarcopenia based on ICF[J]. Chinese Journal of Rehabilitation Theory and Practice, 2024, 30(3): 273-280.

图/表 2

表1

基于ICF肌少症功能测量工具的内容分析"

测量工具	测量项目	ICF编码
SARC-F	1.力量	肌肉力量功能(b730)
	2.行走辅助	步行(d450)
	3.从椅子起立	改变身体的基本姿势(d410)
	4.爬楼梯	攀登(d4551)
	5.跌倒	不随意运动反应功能(b755)
Ishii测试	1.握力	肌肉力量功能(b730)
Ishii测试	2.小腿围	体重维持功能(b530)
MSRA-7	1.握力测试	独立肌肉和肌群的力量(b7300)
	2.下肢力量测试	下半身肌肉的力量(b7303)
	3.平衡测试	随意运动控制功能(b760)
	4.功能性移动测试	步行(d450)；到处移动(d455)
	5.行走速度测试	步行(d450)
	6.反应时间测试	不随意运动反应功能(b755 )
	7.耐力测试	肌肉耐力功能(b740)
6MWT	6 min内可以在平坦、坚硬的表面上快速行走的距离	步行(d450)
SPPB	1.椅子站立测试(不使用手臂的五次重复椅子站立)	改变身体的基本姿势(d410)
	2.站立平衡(站立平衡的渐进式测试)	随意运动控制功能(b760)
	3.步行速度(4 m的常规步伐步行)	步行(d450)
BI	1.进食	吃(d550)；喝(d560)
	2.洗澡	盥洗自身(d510)
	3.修饰	护理身体各部(d520)
	4.穿衣	穿着(d540)
	5.控制大便	控制大便(d5301)
	6.控制小便	控制小便(d5300)
	7.如厕	如厕(d530)
	8.床椅转移	坐姿移动自身(d4200)
	9.平地行走	步行(d450)
	10.上下楼梯	攀登(d4551)
WHODAS 2.0	1.1集中注意力	注意力功能(b140)
	1.2记得做重要的事	记忆功能(b144)
	1.3分析并解决日常生活问题	解决问题(d175)
	1.4学习一项新任务	掌握技能(d155)
	1.5理解别人的言语	交流-接收-口头讯息(d310)
	1.6发起并维持谈话	交谈(d350)
	2.1长时间站立	保持一种身体姿势(d415)
	2.2坐下后站立	改变身体的基本姿势(d410)
	2.3家中来回走动	在不同地点到处移动(d460)
	2.4从家中外出	在不同地点到处移动(d460)
	2.5长距离行走	步行(d450)
	3.1洗澡	盥洗自身(d510)
	3.2穿衣服	穿着(d540)
	3.3进食	吃(d550)
	3.4独立生活数日	进行日常事务(d230)
	4.1与陌生人相处	与陌生人的联系(d730)
	4.2维持一段友情	非正式社会关系(d750)
	4.3同他人密切相处	家庭人际关系(d760)
	4.4结交新朋友	非正式社会关系(d750)
	4.5性活动	亲密关系(d770)
	5.1承担家务劳动责任	照管居家物品(d650)
	5.2完成家务劳动	做家务(d640)
	5.3完成所有家务劳动
	5.4尽快完成家务劳动
	5.5日常工作或学习	学龄前教育(d815)；学校教育(d820)；职业训练(d825)；高等教育(d830)；有报酬的就业(d850)
	5.6很好地完成大多数重要工作或学习
	5.7完成份内所有工作
	5.8尽可能完成工作
	6.1像他人一样参与社区活动	社区生活(d910)
	6.2“有尊严的活着”的困难	人权(d940)
	6.3健康问题及影响上花费时间	照顾个人的健康(d570)
	6.4健康问题对家庭带来的经济损失	经济自给(d870)
	6.5自我放松或娱乐方面的困难	娱乐和休闲(d920)

表1

表2

肌少症测量工具心理测量特性"

测量工具	适应人群	心理测量特性	心理测量特性指标
SARC-F	初步筛查患有肌少症的老年人群	敏感性较低，特异性优秀	敏感性29.5% (95%CI 18.5%~42.6%) 特异性98.1% (95%CI 96.0%~99.3%)
SARC-F	初步筛查患有肌少症的老年人群	敏感性较低~中等，特异性中等~良好	敏感性28.9%~55.3% (95%CI 11.8%~61.6%) 特异性68.9%~88.9% (95%CI 76.0~98.8%) Youden指数0.00~0.64
Ishii测试	需评估肌肉质量的老年人群	敏感性中等~良好，特异性一般~良好与女性群体相比，在男性群体中的敏感性、差异性、诊断效果更好	男性：敏感性88.9%；特异性70.6% AUC：0.87 女性：敏感性77.8%；特异性68.6% AUC：0.78
Ishii测试	需评估肌肉质量的老年人群	敏感性优秀，特异性较低，诊断效果中等，分类模型性能中等	敏感性90.1%；特异性36.0% AUC：0.78；Youden指数0.5
MSRA	有肌肉减少风险的老年人群	MSRA-7敏感性良好，特异性一般，诊断效果中等 MSRA-5敏感性良好，特异性一般，诊断效果中等	MSRA-7 敏感性80.4%；特异性50.5% AUC：0.786 (95%CI 0.725~0.847) MSRA-5 敏感性80.4%；特异性60.4% AUC：0.789 (95%CI 0.728~0.851)
MSRA	有肌肉减少风险的老年人群	MSRA-7敏感性中等，特异性一般，诊断效果一般 MSRA-5敏感性一般，特异性一般，诊断效果中等	MSRA-7 敏感性75.7%；特异性65.1% AUC:0.666 (95%CI 0.542~0.789) MSRA-5 敏感性68.8%；特异性67.9% AUC: 0.710 (95%CI 0.593~0.827)
6MWT	心肺功能障碍群体老年患者	敏感性一般~中等，特异性一般，诊断效果一般~中等与女性群体相比，在男性群体中的敏感性、特异性、诊断效果更好	男性：敏感性71%；特异性63% AUC：0.720 (95%CI 0.628~0.690) 女性：敏感性69%；特异性58% AUC：0.692 (95%CI 0.623~0.755)
SPPB	老年患者	敏感性一般，特异性一般~中等，诊断效果一般~优秀	敏感性42%~58%；特异性69%~71% AUC：0.69~0.98
BI	脑卒中患者肌少症患者肿瘤患者	信度良好	信度(Cronbach α) > 0.85
WHODAS 2.0	所有患病人群一般人群	信度优秀	信度(Cronbach α) > 0.90

表2

参考文献 33

[1]	CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European Consensus on Definition and Diagnosis[J]. Age Ageing, 2019, 48(1): 16-31. doi: 10.1093/ageing/afy169
[2]	KIM H, HIRANO H, EDAHIRO A, et al. Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults[J]. Geriatr Gerontol Int, 2016, 16 (Suppl 1): 110-122. doi: 10.1111/ggi.2016.16.issue-s1
[3]	JUBY A G, DAVIS C M J, MINIMAANA S, et al. Observational cohort study of highly functioning community-dwelling older adults to assess their sarcopenic status, leisure physical activity, and quality of life over 12-months[J]. Heliyon, 2023, 9(9): e20078. doi: 10.1016/j.heliyon.2023.e20078
[4]	CHEN L K, WOO J, ASSANTACHAI P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307.e2. doi: 10.1016/j.jamda.2019.12.012
[5]	KIM S, KIM M, WON C W. Validation of the Korean version of the SARC-F Questionnaire to assess sarcopenia: Korean frailty and aging cohort study[J]. J Am Med Dir Assoc, 2018, 19(1): 40-56. doi: S1525-8610(17)30404-8 pmid: 28843526
[6]	LOURENÇO R A, PÉREZ-ZEPEDA M, GUTIÉRREZ-ROBLEDO L, et al. Performance of the European Working Group on Sarcopenia in Older People algorithm in screening older adults for muscle mass assessment[J]. Age Ageing, 2015, 44(2): 334-348. doi: 10.1093/ageing/afu192 pmid: 25539836
[7]	BEAUDART C, REGINSTER J Y, GEERINCK A, et al. Current review of the SarQoL^®: a health-related quality of life questionnaire specific to sarcopenia[J]. Expert Rev Pharmacoecon Outcomes Res, 2017, 17(4): 335-341. doi: 10.1080/14737167.2017.1360768
[8]	世界卫生组织. 国际功能、残疾和健康分类(国际中文增补版)[M]. 邱卓英,译. 日内瓦: 世界卫生组织, 2015.
	World Health Organization. International Classification of Functioning, Disability and Health-International (Chinese Supplement)[M]. QIU Z Y, trans trans. Geneva: World Health Organization, 2015.
[9]	邱卓英, 李伦, 陈迪, 等. 基于世界卫生组织国际健康分类家族康复指南研究:理论架构和方法体系[J]. 中国康复理论与实践, 2020, 26(2): 125-135. doi: 10.3969/j.issn.1006-9771.2020.02.001
	QIU Z Y, LI L, CHEN D, et al. Research on rehabilitation guidelines using World Health Organization Family International Classifications: framework and approaches[J]. Chin J Rehabil Theory Pract, 2020, 26(2): 125-135.
[10]	CIEZA A, FAYED N, BICKENBACH J, et al. Refinements of the ICF linking rules to strengthen their potential for establishing comparability of health information[J]. Disabil Rehabil, 2019, 41(5): 574-583. doi: 10.3109/09638288.2016.1145258 pmid: 26984720
[11]	MALMSTROM T K, MILLER D K, SIMONSICK E M, et al. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes[J]. J Cachexia Sarcopenia Muscle, 2016, 7(1): 28-36. doi: 10.1002/jcsm.12048 pmid: 27066316
[12]	MALMSTROM T K, MORLEY J E. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia[J]. J Am Med Dir Assoc, 2013, 14(8): 531-532. doi: 10.1016/j.jamda.2013.05.018 pmid: 23810110
[13]	YANG M, HU X, XIE L, et al. Comparing Mini Sarcopenia Risk Assessment with SARC-F for screening sarcopenia in community-dwelling older adults[J]. J Am Med Dir Assoc, 2019, 20(1): 53-57. doi: S1525-8610(18)30229-9 pmid: 29909052
[14]	VOELKER S N, MICHALOPOULOS N, MAIER A B, et al. Reliability and concurrent validity of the SARC-F and its modified versions: a systematic review and meta-analysis[J]. J Am Med Dir Assoc, 2021, 22(9): 1864-1876.e16. doi: 10.1016/j.jamda.2021.05.011 pmid: 34144049
[15]	IDA S, NAKAI M, ITO S, et al. Association between sarcopenia and mild cognitive impairment using the Japanese version of the SARC-F in elderly patients with diabetes[J]. J Am Med Dir Assoc, 2017, 18(9): 809. e9-809.e13.
[16]	ISHII S, TANAKA T, SHIBASAKI K, et al. Development of a simple screening test for sarcopenia in older adults[J]. Geriatr Gerontol Int, 2014, 14(Suppl 1): 93-101. doi: 10.1111/ggi.2014.14.issue-s1
[17]	LI M, KONG Y, CHEN H, et al. Accuracy and prognostic ability of the SARC-F questionnaire and Ishii's score in the screening of sarcopenia in geriatric inpatients[J]. Braz J Med Biol Res, 2019, 52(9): e8204. doi: 10.1590/1414-431x20198204
[18]	YAO R, YAO L, YUAN C, et al. Accuracy of Calf Circumference Measurement, SARC-F Questionnaire, and Ishii's score for screening stroke-related sarcopenia[J]. Front Neurol, 2022, 13(3): 880907. doi: 10.3389/fneur.2022.880907
[19]	ZHU L, LI J, LI M, et al. Accuracy of SARC-F, SARC-CalF, and Ishii Test in assessing severe sarcopenia in older adults in nursing homes[J]. J Nutr Health Aging, 2022, 26(6): 576-580. doi: 10.1007/s12603-022-1798-4 pmid: 35718866
[20]	LIN X, LI M, LI Z, et al. Evaluation of four methods for the assessment of sarcopenia in older adults in nursing homes[J]. J Nutr Health Aging, 2021, 25(9): 1119-1123. doi: 10.1007/s12603-021-1680-9 pmid: 34725671
[21]	ROSSI A P, MICCIOLO R, RUBELE S, et al. Assessing the risk of sarcopenia in the elderly: the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire[J]. J Nutr Health Aging, 2017, 21(6): 743-749. doi: 10.1007/s12603-017-0921-4 pmid: 28537342
[22]	ROSSI A P, CALIARI C, URBANI S, et al. Sarcopenia risk evaluation in a sample of hospitalized elderly men and women: combined use of the Mini Sarcopenia Risk Assessment (MSRA) and the SARC-F[J]. Nutrients, 2021, 13(2): 635. doi: 10.3390/nu13020635
[23]	ABELLAN VAN KAN G, ROLLAND Y, ANDRIEU S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force[J]. J Nutr Health Aging, 2009, 13(10): 881-889. doi: 10.1007/s12603-009-0246-z pmid: 19924348
[24]	ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test[J]. Am J Respir Crit Care Med, 2002, 166(1): 111-117. doi: 10.1164/ajrccm.166.1.at1102
[25]	LIMA A B, BAPTISTA F, HENRINQUES-NETO D, et al. Symptoms of sarcopenia and physical fitness through the Senior Fitness Test[J]. Int J Environ Res Public Health, 2023, 20(3): 2711. doi: 10.3390/ijerph20032711
[26]	WELCH S A, WARD R E, BEAUCHAMP M K, et al. The Short Physical Performance Battery (SPPB): a quick and useful tool for fall risk stratification among older primary care patients[J]. J Am Med Dir Assoc, 2021, 22(8): 1646-1651. doi: 10.1016/j.jamda.2020.09.038
[27]	PAVASINI R, GURALNIK J, BROWN J C, et al. Short physical performance battery and all-cause mortality: systematic review and meta-analysis[J]. BMC Med, 2016, 14(1): 215. doi: 10.1186/s12916-016-0763-7 pmid: 28003033
[28]	LEE S Y, CHOO P L, PANG B W J, et al. SPPB reference values and performance in assessing sarcopenia in community-dwelling Singaporeans-Yishun study[J]. BMC Geriatr, 2021, 21(1): 213. doi: 10.1186/s12877-021-02147-4
[29]	WADE D T, COLLIN C. The Barthel ADL Index: a standard measure of physical disability?[J]. Int Disabil Stud, 1988, 10(2): 64-67. doi: 10.3109/09638288809164105 pmid: 3042746
[30]	SUGIMOTO T, ONO R, MURATA S, et al. Sarcopenia is associated with impairment of activities of daily living in Japanese patients with early-stage Alzheimer disease[J]. Alzheimer Dis Assoc Disord, 2017, 31(3): 256-258. doi: 10.1097/WAD.0000000000000175
[31]	World Health Organization. WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)[EB/OL]. [2022-12-10]. https://www.who.int/publications/i/item/measuring-health-and-disability-manual-for-who-disability-assessment-schedule-(-whodas-2.0).
[32]	FEDERICI S, BRACALENTI M, MELONI F, et al. World Health Organization Disability Assessment Schedule 2.0: an international systematic review[J]. Disabil Rehabil, 2017, 39(23): 2347-2380. doi: 10.1080/09638288.2016.1223177 pmid: 27820966
[33]	TYROVOLAS S, KOYANAGI A, OLAYA B, et al. The role of muscle mass and body fat on disability among older adults: a cross-national analysis[J]. Exp Gerontol, 2015, 69(2): 27-35. doi: 10.1016/j.exger.2015.06.002

基于ICF的老年肌少症功能测量工具的内容和心理测量特性比较

Content and psychometric properties of functional measurements in patients with sarcopenia based on ICF

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 33

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	张青, 孙建刚, 杨洪荣, 高少宇, 武爱红, 王勇丽. 教育情境下智力与发展性残疾儿童的功能和适应性行为评估：基于ICF评估内容和心理测量特性研究[J]. 《中国康复理论与实践》, 2024, 30(3): 249-256.
[2]	吴亮. 基于ICF儿童发展和适应性行为测量工具的内容和心理测量特性研究[J]. 《中国康复理论与实践》, 2024, 30(3): 257-264.
[3]	王馨婷, 杨剑. 基于ICF的儿童运动功能和活动能力测量工具的内容和心理测量特性研究[J]. 《中国康复理论与实践》, 2024, 30(3): 265-272.
[4]	王航宇, 葛可可, 范永红, 都丽露, 邹敏, 封磊. 基于ICD-11和ICF主动式音乐疗法改善认知障碍老年人认知功能的系统综述[J]. 《中国康复理论与实践》, 2024, 30(1): 36-43.
[5]	葛可可, 范永红, 王航宇, 都丽露, 李长江, 邹敏. 失眠老年人正念干预健康效益的系统综述[J]. 《中国康复理论与实践》, 2024, 30(1): 54-60.
[6]	杨雅楠, 穆丽萍, 邢凤梅, 薛新宏, 王晓光, 陶徉聿, 孙竹梅, 张小丽. 基于计划行为理论的干预对肌少症老年人肌肉衰减状况及平衡能力的效果[J]. 《中国康复理论与实践》, 2023, 29(8): 869-874.
[7]	蒋长好, 黄辰, 高晓妍, 戴元富, 赵国明. 神经反馈训练对老年人认知功能效果的系统综述[J]. 《中国康复理论与实践》, 2023, 29(8): 903-909.
[8]	张瑞明, 王凯, 尹锐, 王海亮, 莫言. 失重条件下舱外手套外骨骼助力效果的评估方法[J]. 《中国康复理论与实践》, 2023, 29(7): 856-861.
[9]	石孝宇, 杨剑. 适用于残疾儿童青少年身体活动测量报告工具结构、内容及心理测量特性的系统综述[J]. 《中国康复理论与实践》, 2023, 29(6): 621-629.
[10]	刘辉, 尹航, 贾绍辉, 邱服冰. 适用于残疾儿童青少年运动功能和运动能力测量工具的结构、内容和心理测量特性的系统综述[J]. 《中国康复理论与实践》, 2023, 29(6): 630-638.
[11]	谭晓欢, 姜桂萍, 黄芯怡, 王丹丹, 张磊, 卜庆国, 吴雪萍. 社区高龄老年人下肢肌力与步速的关系：柔韧和动态平衡的链式中介作用[J]. 《中国康复理论与实践》, 2023, 29(6): 646-653.
[12]	袁媛, 杨剑. 社区老年人身体活动融合慢性病管理的健康效益：Scoping综述[J]. 《中国康复理论与实践》, 2023, 29(5): 541-550.
[13]	薛新宏, 王晓光, 陶徉聿, 李娜, 董静, 薛子娇, 蔡逢雨, 邢凤梅. 营养联合运动干预对脑卒中伴肌少症患者的效果[J]. 《中国康复理论与实践》, 2023, 29(5): 595-600.
[14]	闫媚, 江华, 董理权, 柳博飞, 贺炜洁, 吴小高, 郭智洋. 中国辅助技术的需求、供给和满意度研究：基于快速辅助技术评估数据[J]. 《中国康复理论与实践》, 2023, 29(4): 373-380.
[15]	邱晓, 凌骏麒, 从洋洋, 白玉龙. 3D扫描容积法评定上肢远端体积的信度和效度[J]. 《中国康复理论与实践》, 2023, 29(3): 364-367.